The Chairman of the Board of Directors and the CEO of EU Biotech Campus asbl are delighted with the recruitment of Mr. François Strykers as COO (Chief Operating Officer) of the “EU Biotech Campus” project. This project was initiated at the end of 2021, as part of the National Recovery and Resilience Plan (PNRR) and the Walloon Recovery Plan.
François Strykers brings all his expertise and experience in creating training tools for business development in cutting-edge sectors. With an initial training in human resources management, François has over sixteen years experience as a manager of business units and SMEs within organizations active in a variety of fields in both the private and public sectors. Nine of these sixteen years were spent in the training sector – including five years as director of several training centers, including the Giga Biotech center in Liège. François was also the director of Jobs@skills, the Liège-Luxembourg incubator for training, skills and professions, one of whose priorities is the life sciences. François recently rounded off his academic career with several university certificates in management and an Executive MBA in international business. François’ profile fits perfectly with the high ambitions of the EU Biotech Campus.
Further information can be found on his Linkedin profile.
The EU Biotech Campus is one of the most strategic investments of the National Plan for Recovery and Resilience, financed by the European Union as part of NextGenerationEU, and the Wallonia Recovery Plan. The initiative is designed as a multi-operator talent development platform to support the fast-growing biotech sector. From 2025, the EU Biotech Campus will occupy over 5,000 m² of BIOTECH 5, a brand-new 25,000 m² building next to Charleroi airport.
Located in the heart of the BioPark in Gosselies (Charleroi), this ultra-modern training center and business accelerator – supported by essenscia, the chemical and life sciences sector federation – has an ambitious mission: to train more talent and support more start-ups and scale-ups in order to further strengthen the international position of the Belgian and Walloon biotech and biopharmaceutical sector, as well as prepare them for the next-generation biotech production processes and new digital skills.